All In Biotech

Free tool

FAERS Monitor: Sutab

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 213135 or its brand name (Sutab, Magnesium Sulfate, Potassium Chloride, Sodium Sulfate). Reports on generic versions are filed under their own applications.

Reports

1,589

Serious

211

13% of reports

Hospitalization

42

Death reported

2

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • vomiting827
  • nausea424
  • drug ineffective141
  • abdominal distension94
  • headache94
  • abdominal pain upper88
  • pruritus66
  • wrong technique in product usage process65
  • abdominal pain63
  • dizziness62
  • tremor61
  • chills56
  • malaise56
  • hypersensitivity51
  • diarrhoea48

Reports by year received

View as table
YearReports
20181
20202
2021263
2022438
2023426
202446
2025397
202616

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,570 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
vomitingSignal82723.322.218,018
abdominal distensionSignal9411.99.8934
nauseaSignal4247.16.52,299
chillsSignal566.34.9247
abdominal pain upperSignal885.74.6336
tremorSignal614.93.8185
wrong technique in product usage processSignal654.23.3160
hypersensitivitySignal513.62.896
abdominal painSignal633.62.8116
pruritusSignal662.31.847
headache942.01.646
malaise561.71.315
dizziness621.61.315
drug ineffective1411.41.218
diarrhoea481.00.70

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.